Tuesday, September 17, 2024

Augmedix to Join Forces with Commure

Related stories

Cohesity & CrowdStrike Expand for Better Threat Detection

Cohesity, a leader in AI-powered data security, announced an...

Salesforce Unveils Agentforce–What AI Was Meant to Be

Agentforce is how humans with AI drive customer success...

Massive Bio & Foundation Medicine Enhance Trial Recruitment

Massive Bio, a cutting-edge AI driven clinical trial matching...

Metify & SecEdge Form Secure “Root of Trust” Alliance

Metify.io, a pioneer in secure zero-touch server provisioning (ZTP),...

Intelecy announces Anna Olsson’s promotion to Chief Operating Officer

Intelecy, a leading Norwegian industrial AI company, is excited...
spot_imgspot_img

Augmedix, Inc., a leader in ambient AI medical documentation and data solutions, announced that it has entered into a definitive agreement to be acquired by Commure, Inc., a leading provider of technology to healthcare systems, in an all-cash transaction that values Augmedix at approximately $139 million in equity value.

Under the terms of the agreement, Augmedix stockholders will receive $2.35 per share in cash upon completion of the proposed transaction, and Augmedix will become a wholly-owned subsidiary of Commure. The purchase price represents a premium of approximately 169% over the volume weighted average price (VWAP) of Augmedix’s common stock for the 30 days ending July 18, 2024.

Also Read: HeartFlow Introduces Next Generation Interactive Plaque Analysis Platform to Assess Patient Risk in Suspected Coronary Artery Disease

“This proposed transaction with Commure provides certainty and a premium value for our stockholders, representing a transformative next step in Augmedix’s mission to unburden clinicians of administrative tasks while dramatically improving health system efficiency,” said Manny Krakaris, Chief Executive Officer at Augmedix. “As part of Commure, we believe Augmedix will be well-positioned to scale ambient documentation solutions to even more clinicians and health systems while simultaneously accelerating efforts to infuse more innovative features, integrations, and AI capabilities into our product suite. Importantly, Commure is strongly aligned with Augmedix’s mission and vision for the future. We believe that the significant resources, deep industry expertise, and broadened technology capabilities we gain through this transaction will strengthen our market position, enable us to take advantage of more opportunities and create a powerful, future-focused company. We look forward to continuing to serve our customers and support our employees who are relentless in their pursuit of better clinical, operational, and financial outcomes.”

“Through our acquisition of Augmedix,” added Tanay Tandon, Chief Executive Officer at Commure, “we’re taking a huge step forward in building the health AI operating system of the future, using language models to consolidate various point solutions into a single, integrated platform for providers, clinical operations teams, and healthcare IT.”

Source: GlobeNewsWire

Subscribe

- Never miss a story with notifications


    Latest stories

    spot_img